Open-label trial to evaluate the efficacy and safety of the use of argatroban in patients with heparin-induced thrombocytopenia.
Phase of Trial: Phase III
Latest Information Update: 20 May 2016
At a glance
- Drugs Argatroban (Primary)
- Indications Heparin-induced thrombocytopenia and thrombosis syndrome
- Focus Adverse reactions
- Acronyms ARG-HIT-CVD
- 12 Nov 2008 Additional trial acronym ARG-HIT-CVD identified as reported by ClinicalTrials.gov.
- 11 Dec 2005 New trial record.